dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Janin, Maxime |
dc.contributor.author | Ortiz‑Barahona, Vanessa |
dc.contributor.author | Castro de Moura, Manuel |
dc.contributor.author | Martínez‑Cardús, Anna |
dc.contributor.author | Llinàs‑Arias, Pere |
dc.contributor.author | Soler, Marta |
dc.contributor.author | Arias Piñeiro, Alexandra |
dc.contributor.author | Cuartas Maza, Ma Isabel |
dc.contributor.author | Seoane Suarez, Joan |
dc.date.accessioned | 2021-04-16T11:08:52Z |
dc.date.available | 2021-04-16T11:08:52Z |
dc.date.issued | 2019-12 |
dc.identifier.citation | Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler M, et al. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol. 2019 Dec;138(6):1053–74. |
dc.identifier.issn | 1432-0533 |
dc.identifier.uri | https://hdl.handle.net/11351/5869 |
dc.description | Resultado clínico; Epitranscriptómica; Glioma |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Acta Neuropathologica;138(6) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Gliomes |
dc.subject | Metiltransferases |
dc.subject.mesh | Glioma |
dc.subject.mesh | Methyltransferases |
dc.title | Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s00401-019-02062-4 |
dc.subject.decs | glioma |
dc.subject.decs | metiltransferasas |
dc.relation.publishversion | https://link.springer.com/article/10.1007%2Fs00401-019-02062-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler M] Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet, Barcelona, Catalonia, Spain. [Arias A, Cuartas I] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Seoane J] Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain |
dc.identifier.pmid | 31428936 |
dc.identifier.wos | 000496124600009 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/FP7/FP7%2F2007-2013 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2014-55000-R |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01278 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PIE13%2F00022 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00312 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2009SGR1315 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |